Cancer Survivors Club 📙

Breaking cancer news, research breakthroughs & survivor stories; all evidence-based, never hype. Follow for progress, hope & real science. #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

I share evidence-based cancer news, research breakthroughs and survivor stories — no hype, no miracle cures.

This feed is for patients, families, clinicians and anyone who believes progress matters.

Follow for facts, hope & real science!

Curated by @Chris_Geiger
#TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

A powerful reminder of the value of genetic testing. After discovering he carried a mutation linked to leukaemia, Jerry Brouwer received specialist care and a stem cell transplant. He now has no evidence of cancer.

https://t.co/DIszYuXHRZ

#Leukaemia #CancerSurvivor #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

More patients will soon have access to precision radiotherapy! Nebraska Medicine plans to open a proton therapy centre in 2027, helping patients across seven US states receive targeted cancer treatment closer to home.

https://t.co/H68WF9Gtqp

#CancerCare #Radiotherapy #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Encouraging pancreatic cancer progress! City of Hope reports that a Phase 3 trial of the KRAS-targeting drug daraxonrasib extended survival by nearly six months compared with chemotherapy in advanced disease.

https://t.co/WkXhprh6qE

#PancreaticCancer #CancerResearch #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

An extraordinary brain cancer survival story! Given just 17 months to live after a glioblastoma diagnosis, Jamil Newirth is thriving 14 years later. He received an experimental personalised cancer vaccine in a UCLA trial.

https://t.co/q1R51OeNwn

#BrainCancer #Cancer #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Scientists have discovered how cancer cells use an antioxidant protein to weaken the immune system. Blocking this defence restored immune activity and improved immunotherapy responses, opening a promising research avenue.

https://t.co/1HQNW9L2Fi

#Cancer #Immunotherapy #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

An inspiring brain cancer story! Nearly two years after his glioblastoma diagnosis, Gary McLouth is looking ahead to family milestones after receiving standard treatment and an experimental immunotherapy vaccine called SurVaxM.

https://t.co/PQQbPAgvP4

#BrainCancer #Cancer #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Twenty years of progress in lung cancer care! Immunotherapy has transformed treatment, some clinical trials reporting five-year survival rates above 30% in patients. Researchers are now working to extend these benefits to more people.

https://t.co/BWpGVlnMlY

#LungCancer #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

New hope for advanced melanoma! MD Anderson reports a 66.7% tumour response rate at the recommended Phase 2 dose of an experimental engineered T-cell therapy in patients whose cancer resisted previous immunotherapy.

https://t.co/iCe2P1V2WD

#Melanoma #Immunotherapy #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Major progress in bladder cancer! A Phase 3 trial found that combining durvalumab and enfortumab vedotin around surgery reduced the risk of death by 42% in patients unable or unwilling to receive standard cisplatin chemotherapy.

https://t.co/mjX2q4w1Qs

#BladderCancer #TCSC

[NHS Blood Donation 🩸🩹 @GiveBloodNHS]

Remember, remember... to give blood this November. 🎆

Your donation could help someone get their spark back. ✨

Thank you to everyone donating today. Have a fantastic #BonfireNight and enjoy the celebrations!

#GiveBlood

[Cancer Survivors Club 📙 @Cancer_Buzz]

Could a blood test help patients avoid unnecessary chemo? Tumour-informed DNA testing may help doctors identify who needs more intensive treatment and who could safely receive less. An important area of ongoing research.

https://t.co/hw9UttLt0y

#PrecisionMedicine #Cancer #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Seven years after an experimental personalised mRNA vaccine alongside surgery & chemo, pancreatic cancer survivor Donna Gustafson remains cancer-free. Her remarkable story offers encouragement for future cancer vaccine research.

https://t.co/JBmjXrGh6S

#PancreaticCancer #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

A little light is making a difference! At St. Jude, young brain tumour patient Sloane has benefited from red-light therapy to relieve painful mouth sores caused by treatment, helping restore her comfort and energy.

https://t.co/5ofztK12r0

#ChildhoodCancer #CancerCare #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Encouraging bladder cancer news! A trial found 75% of patients receiving enfortumab vedotin and pembrolizumab around surgery remained in remission after two years, compared with 39% receiving surgery alone.

https://t.co/VfIKWs5QF5

#BladderCancer #CancerResearch #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Major progress in lung cancer treatment! A Phase 3 trial found that adding tarlatamab to durvalumab extended median survival from 12.7 to 21.1 months in extensive-stage small cell lung cancer.

https://t.co/QtiuECK2Lp

#LungCancer #Immunotherapy #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Over 700 people registered for the Betty Puskar Breast Cancer Walk in West Virginia, celebrating survivors and supporting patients. The event helps raise funds for education, early detection and better cancer care.

https://t.co/KzRNrzKq42

#BreastCancer #CancerSurvivors #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Cancer spreading to the brain doesn’t mean treatment options have run out. Surgery, targeted radiation and medicines can all play a role. Mayo Clinic specialists explain how personalised treatment plans are developed.

https://t.co/2Nlkj98DyP

#BrainMetastases #CancerCare #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Why can bowel cancer be harder to treat in younger patients? Scientists studying 189 tumours found differences in cells surrounding the cancer that could help identify new treatment targets.

https://t.co/TQSqR8wfUM

#BowelCancer #CancerResearch #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Encouraging lung cancer research! A Phase 3 trial is testing nivolumab, relatlimab and chemotherapy after earlier results showed improved tumour responses in certain patients with advanced non-small cell lung cancer.

https://t.co/UpNuVJqqsz

#LungCancer #Immunotherapy #TCSC

[Cancer Survivors Club 📙 @Cancer_Buzz]

Sound waves could help fight brain cancer! Scientists at the University of Virginia are testing focused ultrasound & nanoparticles to deliver gene-targeting molecules against glioblastoma. Early results are encouraging.

https://t.co/Fvitqp5f9G

#BrainCancer #CancerResearch #TCSC